로딩 중…
지수 로딩 중…
Tyra Biosciences, Inc.
TYRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$28.32-2.58%
2026-06-18
Price Chart
Tyra Biosciences, Inc.+198.11%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.68B |
| Revenue | $0.00 |
| Net Income | $-131M |
| Total Assets | $412M |
| Net Assets | $388M |
| Value | |
| P/B | 4.35x |
| FCF Yield | -6.08% |
| Profitability | |
| ROE | -33.83% |
| ROA | -31.82% |
| Financial Health | |
| Debt Ratio | 6.31% |
| Total Debt | $6M |
| FCF | $-102M |
| Cash | $85M |
| Current Ratio | 20.49x |
| Performance | |
| 1Y Return | 198.11% |
| 1M Return | -16.16% |
| From 52W High | -30.33% |
| 1Y MDD | -35.82% |
| Trading | |
| Volume | 1,711,570 shares |
| Trading Value | $49M |
| Per Share | |
| EPS | $-2.01 |
| BPS | $4.35 |